Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 314Carcinoma, Non-Small-Cell Lung 161Breast Neoplasms 125Neoplasm Metastasis 105Melanoma 94Leukemia, Myeloid, Acute 80Lymphoma 79Multiple Myeloma 74Colorectal Neoplasms 73Ovarian Neoplasms 69Lymphoma, Non-Hodgkin 63Recurrence 58Prostatic Neoplasms 55Pancreatic Neoplasms 51Lung Neoplasms 49Glioblastoma 39Carcinoma, Renal Cell 39Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, Large B-Cell, Diffuse 37Leukemia, Lymphocytic, Chronic, B-Cell 37Leukemia 36Advanced Solid Tumors 36Myelodysplastic Syndromes 35Triple Negative Breast Neoplasms 33Head and Neck Neoplasms 33Sarcoma 31Brain Neoplasms 31Urinary Bladder Neoplasms 30Stomach Neoplasms 30Lymphoma, Follicular 28

Interventions

pevonedistat 2Paclitaxel 2Docetaxel 2Carboplatin 2Rifampin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Has results × Advanced Solid Neoplasm × Clear all
NCT03330106 2023-03-28

A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
68 enrolled 18 charts

Advanced Solid Neoplasm

NCT03486314 2022-04-18

A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
20 enrolled 18 charts

Advanced Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡